In a study by Hinsenveld et al., 100% sensitivity and 94% accuracy for para-aortic nodal staging were shown in patients with intermediate and high risk prostate cancer when sentinel node biopsy was added to PSMA-PET/CT imaging [18]. The gene discussed is FOLH1; the disease is prostate carcinoma.